Market Overview:
The global pharmacovigilance market grew at a CAGR of around 10% during 2015-2020. Pharmacovigilance (PV) is the pharmacological science concerning the detection, assessment, understanding and prevention of unfavorable effects with pharmaceutical products. It plays a pivotal role in identifying previously unknown adverse effects, recognizing changes in the frequency or severity, and assessing the risks and benefits of drugs to determine required actions. It also ensures the accuracy of communicated information to healthcare professionals and patients. At present, PV is widely used to understand the effects of drugs on individuals worldwide.
The increasing prevalence of lifestyle diseases, such as hypertension, diabetes, and cardiac disorders, has resulted in the rising consumption of drugs worldwide. This, in confluence with the growing incidences of adverse drug reactions (ADRs), represents one of the key factors driving the global pharmacovigilance market. Besides this, the key players are introducing advanced platforms to ensure automated ADR reporting, which is contributing to the market growth. They are also focusing on improving the manufacturing operations and streamlining research and development (R&D) on account of a competitive environment. Furthermore, leading pharmaceutical companies are undertaking numerous initiatives to conduct clinical trials and generate awareness about the proper utilization of medicines. This, in turn, is facilitating the growth of the pharmacovigilance market. Additionally, the coronavirus disease (COVID-19) outbreak has resulted in the urgent need for a vaccine, which has created numerous opportunities for the market players. Apart from this, pharmaceutical manufacturers are shifting towards outsourcing pharmacovigilance operations to third parties on account of the associated benefits, such as increasing internal resource flexibility and better outcomes over shorter periods. Looking forward, IMARC Group expects the global pharmacovigilance market to exhibit strong growth during the next five years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmacovigilance market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, service provider, product life cycle, type, process flow, therapeutic area and end use.
Breakup by Service Provider:
- In-house
- Contract Outsourcing
Breakup by Product Life Cycle:
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
Breakup by Type:
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
Breakup by Process Flow:
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing and Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review and Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
Breakup by Therapeutic Area:
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
Breakup by End Use:
- Pharmaceuticals Companies
- Biotechnology Companies
- Medical Device Companies
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture plc, ArisGlobal LLC, BioClinica Inc. (Cinven Partners LLP), Capgemini, Cognizant, International Business Machines Corporation, ICON plc., IQVIA Inc., ITClinical, Parexel International Corporation and Wipro Limited.
Key Questions Answered in This Report:
- How has the global pharmacovigilance market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global pharmacovigilance market?
- What are the key regional markets?
- What is the breakup of the market based on the service provider?
- What is the breakup of the market based on the product life cycle?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the process flow?
- What is the breakup of the market based on the therapeutic area?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global pharmacovigilance market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pharmacovigilance Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Service Provider
6.1 In-house
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Contract Outsourcing
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product Life Cycle
7.1 Pre-clinical
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Phase I
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Phase II
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Phase III
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Phase IV
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Type
8.1 Spontaneous Reporting
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Intensified ADR Reporting
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Targeted Spontaneous Reporting
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cohort Event Monitoring
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 EHR Mining
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Process Flow
9.1 Case Data Management
9.1.1 Market Trends
9.1.2 Major Types
9.1.2.1 Case Logging
9.1.2.2 Case Data Analysis
9.1.2.3 Medical Reviewing and Reporting
9.1.3 Market Forecast
9.2 Signal Detection
9.2.1 Market Trends
9.2.2 Major Types
9.2.2.1 Adverse Event Logging
9.2.2.2 Adverse Event Analysis
9.2.2.3 Adverse Event Review and Reporting
9.2.3 Market Forecast
9.3 Risk Management System
9.3.1 Market Trends
9.3.2 Major Types
9.3.2.1 Risk Evaluation System
9.3.2.2 Risk Mitigation System
9.3.3 Market Forecast
10 Market Breakup by Therapeutic Area
10.1 Oncology
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Neurology
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Cardiology
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Respiratory Systems
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 Market Breakup by End Use
11.1 Pharmaceuticals Companies
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Biotechnology Companies
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Medical Device Companies
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Others
11.4.1 Market Trends
11.4.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Accenture plc
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 ArisGlobal LLC
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.3 BioClinica Inc. (Cinven Partners LLP)
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.3.3 SWOT Analysis
17.3.4 Capgemini
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.5 Cognizant
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 International Business Machines Corporation
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 Financials
17.3.6.4 SWOT Analysis
17.3.7 ICON plc.
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.7.4 SWOT Analysis
17.3.8 IQVIA Inc.
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.8.4 SWOT Analysis
17.3.9 ITClinical
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.10 Parexel International Corporation
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.10.3 SWOT Analysis
17.3.11 Wipro Limited
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.11.3 Financials
17.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Pharmacovigilance Market: Major Drivers and Challenges
Figure 2: Global: Pharmacovigilance Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Pharmacovigilance Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Pharmacovigilance Market: Breakup by Service Provider (in %), 2020
Figure 5: Global: Pharmacovigilance Market: Breakup by Product Life Cycle (in %), 2020
Figure 6: Global: Pharmacovigilance Market: Breakup by Type (in %), 2020
Figure 7: Global: Pharmacovigilance Market: Breakup by Process Flow (in %), 2020
Figure 8: Global: Pharmacovigilance Market: Breakup by Therapeutic Area (in %), 2020
Figure 9: Global: Pharmacovigilance Market: Breakup by End Use (in %), 2020
Figure 10: Global: Pharmacovigilance Market: Breakup by Region (in %), 2020
Figure 11: Global: Pharmacovigilance (In-house) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Pharmacovigilance (In-house) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Pharmacovigilance (Contract Outsourcing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Pharmacovigilance (Contract Outsourcing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Pharmacovigilance (Pre-clinical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Pharmacovigilance (Pre-clinical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Pharmacovigilance (Phase I) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Pharmacovigilance (Phase I) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Pharmacovigilance (Phase II) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Pharmacovigilance (Phase II) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Pharmacovigilance (Phase III) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Pharmacovigilance (Phase III) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Pharmacovigilance (Phase IV) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Pharmacovigilance (Phase IV) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Pharmacovigilance (Spontaneous Reporting) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Pharmacovigilance (Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Pharmacovigilance (Intensified ADR Reporting) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Pharmacovigilance (Intensified ADR Reporting) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Pharmacovigilance (Cohort Event Monitoring) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Pharmacovigilance (Cohort Event Monitoring) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Pharmacovigilance (EHR Mining) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Pharmacovigilance (EHR Mining) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Pharmacovigilance (Case Data Management) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Pharmacovigilance (Case Data Management) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Pharmacovigilance (Signal Detection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Pharmacovigilance (Signal Detection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Pharmacovigilance (Risk Management System) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Global: Pharmacovigilance (Risk Management System) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Global: Pharmacovigilance (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Global: Pharmacovigilance (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Global: Pharmacovigilance (Neurology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Global: Pharmacovigilance (Neurology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Global: Pharmacovigilance (Cardiology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Global: Pharmacovigilance (Cardiology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Global: Pharmacovigilance (Respiratory Systems) Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Global: Pharmacovigilance (Respiratory Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Global: Pharmacovigilance (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Global: Pharmacovigilance (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Global: Pharmacovigilance (Pharmaceuticals Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Global: Pharmacovigilance (Pharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Global: Pharmacovigilance (Biotechnology Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Global: Pharmacovigilance (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Global: Pharmacovigilance (Medical Device Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Global: Pharmacovigilance (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Global: Pharmacovigilance (Other End Uses) Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Global: Pharmacovigilance (Other End Uses) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: North America: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: North America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: United States: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: United States: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Canada: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Canada: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Asia-Pacific: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Asia-Pacific: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: China: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: China: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Japan: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Japan: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: India: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: India: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: South Korea: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: South Korea: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Australia: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Australia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Indonesia: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Indonesia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Europe: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Europe: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Germany: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Germany: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: France: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: France: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: United Kingdom: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 88: United Kingdom: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 89: Italy: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 90: Italy: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 91: Spain: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 92: Spain: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 93: Russia: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 94: Russia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 95: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 96: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 97: Latin America: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 98: Latin America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 99: Brazil: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 100: Brazil: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 101: Mexico: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 102: Mexico: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 103: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 104: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 105: Middle East and Africa: Pharmacovigilance Market: Sales Value (in Million US$), 2015 & 2020
Figure 106: Middle East and Africa: Pharmacovigilance Market: Breakup by Country (in %), 2020
Figure 107: Middle East and Africa: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 108: Global: Pharmacovigilance Industry: SWOT Analysis
Figure 109: Global: Pharmacovigilance Industry: Value Chain Analysis
Figure 110: Global: Pharmacovigilance Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Pharmacovigilance Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Pharmacovigilance Market Forecast: Breakup by Service Provider (in Million US$), 2021-2026
Table 3: Global: Pharmacovigilance Market Forecast: Breakup by Product Life Cycle (in Million US$), 2021-2026
Table 4: Global: Pharmacovigilance Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 5: Global: Pharmacovigilance Market Forecast: Breakup by Process Flow (in Million US$), 2021-2026
Table 6: Global: Pharmacovigilance Market Forecast: Breakup by Therapeutic Area (in Million US$), 2021-2026
Table 7: Global: Pharmacovigilance Market Forecast: Breakup by End Use (in Million US$), 2021-2026
Table 8: Global: Pharmacovigilance Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 9: Global: Pharmacovigilance Market: Competitive Structure
Table 10: Global: Pharmacovigilance Market: Key Players